AU2001285018A1 - Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer - Google Patents
Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancerInfo
- Publication number
- AU2001285018A1 AU2001285018A1 AU2001285018A AU8501801A AU2001285018A1 AU 2001285018 A1 AU2001285018 A1 AU 2001285018A1 AU 2001285018 A AU2001285018 A AU 2001285018A AU 8501801 A AU8501801 A AU 8501801A AU 2001285018 A1 AU2001285018 A1 AU 2001285018A1
- Authority
- AU
- Australia
- Prior art keywords
- catrf2e11
- cancer
- useful
- detection
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22632900P | 2000-08-17 | 2000-08-17 | |
US60/226,329 | 2000-08-17 | ||
PCT/US2001/025782 WO2002014361A2 (en) | 2000-08-17 | 2001-08-17 | NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001285018A1 true AU2001285018A1 (en) | 2002-02-25 |
Family
ID=22848496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001285018A Abandoned AU2001285018A1 (en) | 2000-08-17 | 2001-08-17 | Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001285018A1 (en) |
WO (1) | WO2002014361A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001287639A1 (en) * | 2000-07-28 | 2002-02-13 | Ulrich Wissenbach | Trp8, trp9 and trp10, markers for cancer |
JP4431503B2 (en) * | 2003-01-08 | 2010-03-17 | 株式会社東京大学Tlo | Factors that promote calcium absorption |
DK1988163T3 (en) * | 2006-02-22 | 2012-08-20 | Int Inst Cancer Immunology Inc | HLA-A * 3303-LIMITED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME |
WO2015131035A1 (en) | 2014-02-27 | 2015-09-03 | Lycera Corporation | Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma & related therapeutic methods |
US9896441B2 (en) | 2014-05-05 | 2018-02-20 | Lycera Corporation | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease |
JP6523337B2 (en) | 2014-05-05 | 2019-05-29 | リセラ・コーポレイションLycera Corporation | Benzenesulfonamides and related compounds for use as agonists of ROR.gamma. And disease treatment |
JP2018515491A (en) | 2015-05-05 | 2018-06-14 | リセラ・コーポレイションLycera Corporation | Dihydro-2H-benzo [b] [1,4] oxazinesulfonamide and related compounds for use as RORγ agonists and disease therapies |
MX2017016134A (en) | 2015-06-11 | 2018-08-15 | Lycera Corp | Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of rory and the treatment of disease. |
EP3717632B1 (en) | 2017-11-30 | 2022-10-26 | F. Hoffmann-La Roche AG | B-cell cultivation method |
WO2022120423A1 (en) * | 2020-12-08 | 2022-06-16 | James Cook University | Peptides and uses thereof |
-
2001
- 2001-08-17 WO PCT/US2001/025782 patent/WO2002014361A2/en active Application Filing
- 2001-08-17 AU AU2001285018A patent/AU2001285018A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002014361A3 (en) | 2003-09-25 |
WO2002014361A2 (en) | 2002-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002318112B2 (en) | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers | |
EP1576104A4 (en) | Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer | |
HK1152714A1 (en) | Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer steap-1 | |
EP1537140A4 (en) | Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer | |
WO2003087306A8 (en) | Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer | |
AU3510200A (en) | Human dickkopf-related protein and nucleic acid molecules and uses therefor | |
EP1517606A4 (en) | Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer | |
EP1622571A4 (en) | Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer | |
AU2002246808A1 (en) | Human nucleic acids and polypeptides and methods of use thereof | |
PT1537140E (en) | Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer | |
AU2002257050A1 (en) | Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer | |
EP1590437A4 (en) | Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer | |
AU2001285018A1 (en) | Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer | |
WO2002083916A8 (en) | Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer | |
AU2002246708A1 (en) | Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer | |
EP1539805A4 (en) | Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer | |
AU2001286541A1 (en) | Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer | |
AU2002254079A1 (en) | Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer | |
EP1565200A4 (en) | Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer | |
WO2003085121A9 (en) | Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer | |
AU2001266813A1 (en) | Human proteins and nucleic acids encoding same | |
AU2001251621A1 (en) | Gtp-binding protein useful in treatment and detection of cancer | |
EP1499350A4 (en) | Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer | |
AU2012244341A1 (en) | Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer | |
EP1545556A4 (en) | Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |